MSME (Udyam registered) Ministry of MSME
- Category
- Small (2023-24)
- Udyam number
- UDYAM-HP-11-0004696
Sorbax Pharmaceuticals Private Limited
Sorbax Pharmaceuticals Private Limited - pharma in Baddi, Himachal Pradesh, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹6.71 Cr
▼ 16% YoY
Net profit · FY 2025
₹7.02 Lakh
Net margin 1%
EBITDA · FY 2025
₹1.18 Cr
EBITDA margin 17.7%
Authorised capital
₹1 Cr
Registered with MCA
Paid-up capital
₹1 Cr
Issued & subscribed
Open charges
₹5.05 Cr
Satisfied ₹4.04 Cr
Company age
6 yrs
Est. 2020
Employees · EPFO
13
Provident fund records
About Sorbax Pharmaceuticals Private Limited
Data last updated:
Sorbax Pharmaceuticals Private Limited is a private limited company based in Baddi, Himachal Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 15 October 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Himachal Pradesh, under CIN U24290HP2020PTC008140. Its GSTIN is 02ABECS6791E1ZC (Himachal Pradesh).
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹1 Cr. It is led by directors including Lalan Kumar Singh and Kota Suresh Prabhu.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No.112 – A Hpsidc Industrial Estate Davni Teh. Baddi Distt. Solan, Himachal Pradesh, India – 173205.
As per the financials filed for FY 2025, the company reported a revenue of ₹6.71 Cr, a decline of 16% compared to the previous year. For the same year it recorded a net profit of ₹7.02 Lakh (net margin 1%) and EBITDA of ₹1.18 Cr (EBITDA margin 17.7%). Revenue has grown at a compounded annual rate (CAGR) of 406% over three years.
The company has about 13 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹5.05 Cr and satisfied charges of ₹4.04 Cr on record.
Sorbax Pharmaceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-HP-11-0004696). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24290HP2020PTC008140
Registration Number 008140
Incorporation Date 15 October 2020
ROC Himachal Pradesh
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-HP-11-0004696
Key People
Lalan Kumar Singh Director Kota Suresh Prabhu Director Dheeraj Gangadhara Shetty Director Recognitions & Rankings of Sorbax Pharmaceuticals
Contact details
Sorbax Pharmaceuticals Private Limited's registered office is in Baddi, Himachal Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressPlot No.112 – A Hpsidc Industrial Estate Davni Teh. Baddi Distt. Solan, Himachal Pradesh, India – 173205
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Sorbax Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Sorbax Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Sorbax Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Sorbax Pharmaceuticals Private Limited, buy the company report.
Financials of Sorbax Pharmaceuticals Private Limited
FY 2025 filings availableSorbax Pharmaceuticals Private Limited reported revenue of ₹6.71 Cr (down 16% YoY) for FY 2025.
Revenue · FY 2025
₹6.71 Cr ▼ 16%
Net profit · FY 2025
₹7.02 Lakh margin 1%
EBITDA · FY 2025
₹1.18 Cr margin 17.7%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 16%
3 years · compounded
▲ 406%
EBITDA CAGR growth
1 year
▲ 3%
3 years · compounded
▲ 106%
Revenue fell 16% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 406%. EBITDA rose 3% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.18 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹7.02 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 17.7% | ||||
| Net Profit Margin | 1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Sorbax Pharmaceuticals Private Limited, buy the company report.
Board of directors of Sorbax Pharmaceuticals Private Limited
Sorbax Pharmaceuticals has 4 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Lalan Kumar Singh | Director | 15 Oct 2020 | 6 Years 0 Months | Current |
| Kota Suresh Prabhu | Director | 15 Oct 2020 | 6 Years 0 Months | Current |
| Dheeraj Gangadhara Shetty Also directs: JPD Pharmaceutical Private Limited | Director | 24 Feb 2021 | 5 Years 8 Months | Current |
| Manjeet Kaur | Director | 26 Apr 2024 | 2 Years 6 Months | Current |
Peer comparison
Sorbax Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Anant Pharmaceuticals Private Limited | ₹6.76 Cr (FY 2025) | 7.0% | Ambernath East, Maharashtra, India | |||
| Samnova Pharmaceuticals Private Limited | ₹6.74 Cr (FY 2025) | 55.0% | Ahmedabad, Gujarat, India | |||
| Sorbax Pharmaceuticals Private Limitedthis company | ₹6.71 Cr (FY 2025) | ₹7.02 Lakh | 1% | -16.0% | Baddi, Himachal Pradesh, India | |
| Experts Pharmaceuticals Private Limited | ₹6.67 Cr (FY 2025) | -30.0% | Ahmedabad, Gujarat, India |
To see the full peer comparison of Sorbax Pharmaceuticals Private Limited, buy the company report.
Auditor
Sorbax Pharmaceuticals Private Limited is audited by M.S. Chambyal & Associates for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| M.S. Chambyal & Associates | FY 2023 | 023927N |
Shareholding
The shareholding of Sorbax Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Sorbax Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹5.05 Cr
Satisfied charges
₹4.04 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 27 Mar 2023 | 100734512 | Others | ₹5.05 Cr | Open | |
| 13 Jul 2021 | 100467096 | Karnataka Bank Ltd. | ₹4.04 Cr | Satisfied |
To see the full charge records of Sorbax Pharmaceuticals Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving Sorbax Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sorbax Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Sorbax Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 02ABECS6791E1ZC | Himachal Pradesh | Active | 20 Oct 2020 |
To see the full GST registrations and return filing status of Sorbax Pharmaceuticals Private Limited, buy the company report.
Recent activity
Sorbax Pharmaceuticals Private Limited has 6 board changes on record since 2020: 5 appointments and 1 cessation. The latest: Manjeet Kaur was appointed as Director on 26 Apr 2024.
AGM
Sorbax Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Sorbax Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Himachal Pradesh.
Appointed
Manjeet Kaur was appointed as Director.
Ceased
Krishan Chand Raghu ceased to be Director.
Charges
A charge registered on 13 Jul 2021 via Charge ID 100467096 with Karnataka Bank Ltd. was fully satisfied on 10 May 2023.
Charges
A charge with Others amounted to Rs. 5.05 Cr with Charge ID 100734512 was registered on 27 Mar 2023.
Charges
A charge with Karnataka Bank Ltd. amounted to Rs. 4.04 Cr with Charge ID 100467096 was registered on 13 Jul 2021.
Appointed
Dheeraj Gangadhara Shetty was appointed as Director.
Appointed
Kota Suresh Prabhu was appointed as Director.
Appointed
Krishan Chand Raghu was appointed as Director.
Appointed
Lalan Kumar Singh was appointed as Director.
Incorporation
15 Oct 2020
Sorbax Pharmaceuticals Private Limited was registered on 15 Oct 2020 with Roc Himachal Pradesh & aged 6 years 21 days as per MCA records.
Frequently asked questions
Sorbax Pharmaceuticals is an active private limited company based in Baddi, Himachal Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 15 October 2020 (6+ years old) and is registered under CIN U24290HP2020PTC008140.
Sorbax Pharmaceuticals has 4 current directors:
- Lalan Kumar Singh - Director
- Kota Suresh Prabhu - Director
- Dheeraj Gangadhara Shetty - Director
- Manjeet Kaur - Director
The latest financial statements of Sorbax Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Sorbax Pharmaceuticals is 02ABECS6791E1ZC, registered in Himachal Pradesh.
The CIN (Corporate Identification Number) of Sorbax Pharmaceuticals is U24290HP2020PTC008140. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sorbax Pharmaceuticals was incorporated on 15 October 2020, making it 6+ years old. It is registered with the Registrar of Companies, Himachal Pradesh.
The peers of Sorbax Pharmaceuticals by revenue are Anant Pharmaceuticals Private Limited, Samnova Pharmaceuticals Private Limited, Experts Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Manjeet Kaur was appointed as Director on 26 Apr 2024. Krishan Chand Raghu ceased to be Director on 20 Mar 2024. Dheeraj Gangadhara Shetty was appointed as Director on 24 Feb 2021. Sorbax Pharmaceuticals has 6 board changes on record in total.
Yes, Sorbax Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-HP-11-0004696).
The registered office of Sorbax Pharmaceuticals is at Plot No.112 – A Hpsidc Industrial Estate Davni Teh. Baddi Distt. Solan, Himachal Pradesh, India – 173205.
Sorbax Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages